Real-world effectiveness and safety of risankizumab in patients with plaque psoriasis in whom guselkumab failed recently: A multicenter retrospective study of switching within the interleukin-23 inhibitor class

Detalles Bibliográficos
Autores principales: Bagit, Ahmed, Maliyar, Khalad, Georgakopoulos, Jorge R., Rankin, Brian, Rimke, Alexander, Mufti, Asfandyar, Le, Heather, Vender, Ronald, Prajapati, Vimal H., Yeung, Jensen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319311/
https://www.ncbi.nlm.nih.gov/pubmed/37409313
http://dx.doi.org/10.1016/j.jdin.2023.05.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319311/
https://www.ncbi.nlm.nih.gov/pubmed/37409313
http://dx.doi.org/10.1016/j.jdin.2023.05.006

Ejemplares similares